The findings and conclusions in these presentations have not been formally disseminated by the Centers for Disease Control and Prevention and should not be construed to represent any agency determination or policy.

Tuesday, May 9, 2006
128

Evaluation of a Multiplex Bead-based Assay for Herpes Simplex Virus-1 and-2 (HSV-1 and HSV-2) Type-specific Serology

Fan Chen, Jules Chen, Harry Prince, Mary Lapé-Nixon, Xin Su, James Song, Wayne Hogrefe, Lilly Kong, and Jan Groen. Focus Diagnostics, Cypress, CA, USA


Background:
HSV-1 and HSV-2 are common human pathogens that cause a variety of clinical manifestations. Adequate identification of HSV type-specific IgG is important for patient management and sero-epidemiological studies, and recently type-specific HSV-1/2 and ELISA assays have become available. A multiplex assay with equivalent sensitivity and specificity is highly desirable. Here we describe the development of a multiplex bead-based assay using Luminex xMAP technology (Austin, TX) for HSV type-specific antibody detection.

Objective:
Determine the accuracy of a Luminex-based HSV type-specific serology assay versus the ELISA

Method:
Samples: A panel consisting of 158 randomly submitted sera for HSV serology and 28 sera positive for CMV, EBV, ANA, HHV6 and rubella were tested.
HSV-1/2 multiplex assay: Luminex bead sets were covalently linked with specific HSV-1 and -2 recombinant antigens (gG1 and gG2), purified whole HSV-1 and -2 antigens, and a goat-anti-human IgG serving as an internal control. Phycoerythrin (PE) conjugated anti-human IgG was used to detect bound IgG. The amount of specific antibodies bound to the respective beads was expressed in MFIs. The HSV-1 and -2 type-specific ELISAs (HerpeSelect) were performed as described by the manufacturer (Focus Diagnostics Inc., CA). An HSV-1and-2 specific inhibition test was considered as the reference method for discrepant samples.


Result:
The sensitivity of the HSV-1/2 specific multiplex bead-based assay for HSV-1 and -2 compared to ELISA was 98.7% and 100%, respectively, with specificity of 98.8% and 99.1% respectively. None of the 28 cross-reactive samples were positive in the HSV-1/2 multiplex bead-based assay. The correlation between the two assay systems in assigning HSV type-specific serostatus to the sera tested was excellent (98.7%).

Conclusion:
The multiplex bead based immunoassays is a very sensitive and specific method for the combined detection of HSV-1/2 antibodies in serum.

Implications:
The Luminex HSV type-specific assay is a capable replacement for ELISA.